Thursday, January 19, 2017 9:44:41 PM
Time Price Volume Market
15:20:02 0.23 962 OTO
13:37:35 0.220299 5000 OTO
13:30:54 0.23 5000 OTO
11:36:52 0.23204 420 OTO
11:35:55 0.24 4215 OTO
10:51:44 0.2399 125 OTO
10:50:47 0.24 16500 OTO
10:50:37 0.23 85 OTO
10:50:32 0.23 8500 OTO
10:50:13 0.23 900 OTO
10:49:59 0.23 2500 OTO
10:49:46 0.23 6300 OTO
10:49:07 0.225 21000 OTO
10:48:55 0.225 200 OTO
10:38:41 0.2201 6000 OTO
10:18:54 0.2127 200 OTO
10:18:54 0.2126 2500 OTO
10:18:47 0.2125 7500 OTO
10:08:32 0.2125 800 OTO
09:31:04 0.225 500 OTO
09:30:13 0.225 3000 OTO
Destiny Media Techno (DSNY)
0.23 ? 0.0 (0.00%)
Volume: 92,207 @ 3:20:02 PM ET
Bid Ask Day's Range
0.22 0.25 0.2125 - 0.24
Recent DSNY News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/27/2024 03:14:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 08:18:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 02:16:42 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/28/2023 11:01:54 AM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 12:08:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 12:01:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:57:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:56:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:49:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:44:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:28:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 10:04:12 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM